Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sotera Health : Records Higher Q2 Profit, Revenue; Updates 2021 Outlook

08/12/2021 | 08:31am EDT


© MT Newswires 2021
All news about SOTERA HEALTH COMPANY
10/15SOTERA HEALTH : Announces Q3 2021 Earnings Release Date
AQ
09/28SOTERA HEALTH : Nelson Labs® and Sterigenics® Open State-of-the-Art Laboratory and Expand ..
AQ
08/27SOTERA HEALTH CO : Termination of a Material Definitive Agreement (form 8-K)
AQ
08/13SOTERA HEALTH : Barclays Adjusts Sotera Health's Price Target to $32 From $30, Keeps Overw..
MT
08/12SOTERA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
08/12SOTERA HEALTH : Reports Second-Quarter and First-Half 2021 Results; Increases 2021 Outlook..
PU
08/12SOTERA HEALTH CO : Results of Operations and Financial Condition (form 8-K)
AQ
08/12SOTERA HEALTH : Records Higher Q2 Profit, Revenue; Updates 2021 Outlook
MT
08/12SOTERA HEALTH : Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q2 Revenue $251.9M, ..
MT
08/12SOTERA HEALTH : Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q2 EPS $0.26, vs. ..
MT
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2021 931 M - -
Net income 2021 126 M - -
Net Debt 2021 1 660 M - -
P/E ratio 2021 57,8x
Yield 2021 -
Capitalization 7 356 M 7 356 M -
EV / Sales 2021 9,68x
EV / Sales 2022 8,55x
Nbr of Employees 3 000
Free-Float 96,2%
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 26,00 $
Average target price 32,44 $
Spread / Average Target 24,8%
EPS Revisions
Managers and Directors
Michael B. Petras Chairman & Chief Executive Officer
Scott J. Leffler Chief Financial Officer & Treasurer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director